Organization · Corporate Venture Capital
LOTTE Ventures U.S.
LOTTE Ventures U.S. is the corporate venture capital arm of LOTTE Group, focusing on seed to Series A investments in biotechnology, robotics, and advanced business initiatives. Established in 2023, it leverages LOTTE's extensive resources to support startups in North America.
Overview
What LOTTE Ventures U.S. does
What LOTTE Ventures U.S. is
LOTTE Ventures U.S. is the corporate venture capital arm of LOTTE Group, focusing on seed to Series A investments in biotechnology, robotics, and advanced business initiatives. Established in 2023, it leverages LOTTE's extensive resources to support startups in North America.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Corporate Venture Capital
- Founded
- Founded in 2023
- Approximate age
- About 3 years
- Structured capabilities
- Funder
- Last reviewed
- May 3, 2026
Official channels
Find LOTTE Ventures U.S. elsewhere
Open the official website or a supported primary organization account.
Capability profile
LOTTE Ventures U.S. as a funder
Investment thesis
LOTTE Ventures U.S. leverages LOTTE Group's infrastructure to support founders in biotech, robotics, and advanced business sectors, emphasizing strategic collaboration and innovation.
Focus narrative
LOTTE Ventures U.S. invests in biotechnology, robotics, and advanced business initiatives. The organization aims to revolutionize supply chain and logistics through next-generation robotics and pursues innovative applications in sectors such as space. Their investment strategy emphasizes leveraging corporate innovation and fostering strategic collaborations.
Value beyond capital
LOTTE Ventures U.S. adds value to its portfolio companies by leveraging LOTTE Group's extensive infrastructure, industry expertise, and global network. The organization emphasizes strategic partnerships, providing access to resources that can accelerate growth and innovation.
Focus and fit
- Stages
- Seed · Series A · Growth Equity
- Sectors
- Biotech & Life SciencesRobotics & Autonomous SystemsArtificial IntelligenceConsumerHealthcare
- Regions
- North America · Global
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 129
Portfolio context
Notable portfolio companies include: Purika: A patented mucin-based longevity and anti-aging consumer product. CuraPatient: An end-to-end digital health solution aimed at improving outcomes and lowering costs. EditCollective (Flexity): An automated SaaS for architectural planning and feasibility review compliance. ReconLabs: A mobile-based AI that converts image collections into 3D assets. Quotabook: A cap-table and equity management platform for East Asian companies. Haegin: A casual game publishing company. SoundPlatform (Munute): An audio/video remastering SaaS. TheOrigin: An original IP creator for webtoons, TV, film, and games. Versework: A user-generated content game publisher. CleaningLab: An on-demand home cleaning service.
Common questions
What to know about LOTTE Ventures U.S.
Upseed classifies LOTTE Ventures U.S. under the Corporate Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 3, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.